Paweł Różanowski
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Surgery top 10%
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
Papers in
- Oncology 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 1
- Co-authors
- Dawid Sigorski (3 shared papers)Ewa Iżycka‐Świeszewska (1 shared paper)Katarzyna Wiktorska (1 shared paper)Kamil Fijorek (1 shared paper)Krzysztof Okoń (1 shared paper)Michał Jarząb (1 shared paper)Barbara Jarząb (1 shared paper)Waldemar Juliusz Placek (1 shared paper)
- Journals
- Targeted Oncology (1 paper)Clinical Cancer Research (1 paper)The Lancet Oncology (1 paper)Współczesna Onkologia (1 paper)Oncology in Clinical Practice (1 paper)
- Partner nations
- PolandCzechiaSouth Korea
In The Last Decade
Paweł Różanowski
8 papers receiving 430 citations
Paweł Różanowski's Hit Papers
Peers
Comparison fields: 5 of 37
- Oncology 196
- Surgery 274
- Otorhinolaryngology 10
- Immunology 31
- Pulmonary and Respiratory Medicine 44
Countries citing papers authored by Paweł Różanowski
This map shows the geographic impact of Paweł Różanowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paweł Różanowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paweł Różanowski more than expected).
Fields of papers citing papers by Paweł Różanowski
This network shows the impact of papers produced by Paweł Różanowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paweł Różanowski. The network helps show where Paweł Różanowski may publish in the future.
Co-authors
The 24 scholars most cited alongside Paweł Różanowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial Hit paper breakdown → | 2020 | 400 |
| 2 | 2025 | 13 | |
| 3 | Optimization of the method of RNA isolation from paraffin blocks to assess gene expression in breast cancer. | 2008 | 8 |
| 4 | 2022 | 6 | |
| 5 | 2017 | 5 | |
| 6 | 2013 | 4 | |
| 7 | 2019 | 1 | |
| 8 | 2019 | 1 | |
| 9 | Ocena wartości prognostycznej i predykcyjnej 21 genowego wskaźnika ryzyka nawrotu nowotworu (recurrence score) we wczesnym raku piersi. Doniesienie wstępne | 2010 | 0 |
About Paweł Różanowski
Paweł Różanowski is a scholar working on Oncology, Hepatology, Dermatology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 9 papers that have together received 438 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (2 papers), Cancer Mechanisms and Therapy (1 paper), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Nonmelanoma Skin Cancer Studies (1 paper), Chemotherapy-induced cardiotoxicity and mitigation (1 paper), Cancer and Skin Lesions (1 paper), Lung Cancer Treatments and Mutations (1 paper) and Biosimilars and Bioanalytical Methods (1 paper). The work is most often cited by research in Oncology (196 citations), Surgery (274 citations), Otorhinolaryngology (10 citations), Immunology (31 citations) and Pulmonary and Respiratory Medicine (44 citations). Paweł Różanowski has collaborated with scholars based in Poland, Czechia and South Korea. Frequent co-authors include Dawid Sigorski, Ewa Iżycka‐Świeszewska, Katarzyna Wiktorska, Kamil Fijorek, Krzysztof Okoń, Michał Jarząb, Barbara Jarząb, Waldemar Juliusz Placek, Mirosława Püsküllüoğlu and Ewa Stobiecka. Their work appears in journals such as Targeted Oncology, Clinical Cancer Research, The Lancet Oncology, Współczesna Onkologia and Oncology in Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.